Xiner Huang

Lika, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.

Journal: Nature communications

Published: April 12, 2024

Author Correction: High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2.

Author Correction: High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2.

Journal: Nature biomedical engineering

Published: January 24, 2024

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination.

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination.

Journal: Cell discovery

Published: August 28, 2023

Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways.

Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways.

Journal: Journal of medical virology

Published: August 08, 2023

Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract.

Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract.

Journal: EBioMedicine

Published: July 31, 2023

The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5.

The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5.

Journal: EBioMedicine

Published: April 19, 2023

Altered host protease determinants for SARS-CoV-2 Omicron.

Altered host protease determinants for SARS-CoV-2 Omicron.

Journal: Science advances

Published: January 20, 2023

High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2.

High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2.

Journal: Nature biomedical engineering

Published: November 21, 2022

Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.

Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.

Journal: Emerging microbes & infections

Published: August 30, 2022

Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2.

Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2.

Journal: Cell reports. Medicine

Published: March 29, 2022

Targeting ACLY efficiently inhibits SARS-CoV-2 replication.

Targeting ACLY efficiently inhibits SARS-CoV-2 replication.

Journal: International journal of biological sciences

Published: March 08, 2022

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.

Journal: Nature

Published: December 23, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026